{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T13:19:53Z","timestamp":1794057593260,"version":"4.8.0"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,6,15]],"date-time":"2023-06-15T00:00:00Z","timestamp":1686787200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Cognitive impairment is a common feature of multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD). However, there is a lack of population-based study of dementia risk in these disorders. In the present study, the risk of dementia in MS and NMOSD patients in Republic of Korea was estimated.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Data analyzed in this study were obtained from the Korean National Health Insurance Service (KNHIS) database between January 2010 and December 2017. The study included 1,347 MS patients and 1,460 NMOSD patients \u226540 years of age who had not been diagnosed with dementia within 1 year prior to the index date. Matched controls were selected based on age, sex, and the presence of hypertension, diabetes mellitus, or dyslipidemia.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In MS and NMOSD patients, the risk of developing any dementia [adjusted hazard ratio (aHR) = 2.34; 95% confidence interval (CI) = 1.84\u20132.96 and aHR = 2.19; 95% CI = 1.61\u20133.00, respectively], Alzheimer\u2019s disease [AD; aHR = 2.23; 95% confidence interval (CI) = 1.70\u20132.91 and aHR = 1.99; 95% CI = 1.38\u20132.88, respectively], and vascular dementia (aHR = 3.75; 95% CI = 1.91\u20137.35 and aHR = 3.21; 95% CI = 1.47\u20137.02, respectively) was higher compared with the matched controls. NMOSD patients had a lower risk of any dementia and AD compared with MS patients after adjusting for age, sex, income, hypertension, diabetes, and dyslipidemia (aHR = 0.67 and 0.62).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The risk of dementia increased in MS and NMOSD patients and dementia risk was higher in MS than in NMOSD.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fnins.2023.1214652","type":"journal-article","created":{"date-parts":[[2023,6,15]],"date-time":"2023-06-15T05:29:22Z","timestamp":1686806962000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":18,"title":["The risk of dementia in multiple sclerosis and neuromyelitis optica spectrum disorder"],"prefix":"10.3389","volume":"17","author":[{"given":"Eun Bin","family":"Cho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Se Young","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Hyung","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohwan","family":"Yeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyungdo","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Wook","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju-Hong","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,6,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.jns.2017.11.022","article-title":"Evaluation of comorbidities and health care resource use among patients with highly active neuromyelitis optica.","volume":"384","author":"Ajmera","year":"2018","journal-title":"J. Neurol. Sci."},{"key":"B2","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/S1474-4422(20)30277-5","article-title":"Cognitive impairment in multiple sclerosis: clinical management, MRI, and therapeutic avenues.","volume":"19","author":"Benedict","year":"2020","journal-title":"Lancet Neurol."},{"key":"B3","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1136\/jnnp.2008.148403","article-title":"Memory impairment in multiple sclerosis: correlation with deep grey matter and mesial temporal atrophy.","volume":"80","author":"Benedict","year":"2009","journal-title":"J. Neurol.Neurosurg. Psychiatry"},{"key":"B4","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1046\/j.1468-1331.2002.00450.x","article-title":"Health-related quality of life and its relationship to cognitive and emotional functioning in multiple sclerosis patients.","volume":"9","author":"Benito-Leon","year":"2002","journal-title":"Eur. J. Neurol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.3174\/ajnr.A3086","article-title":"Subcortical and cortical gray matter atrophy in a large sample of patients with clinically isolated syndrome and early relapsing-remitting multiple sclerosis.","volume":"33","author":"Bergsland","year":"2012","journal-title":"Am. J. Neuroradiol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3233\/JAD-170518","article-title":"Economic burden, mortality, and institutionalization in patients newly diagnosed with Alzheimer\u2019s disease.","volume":"61","author":"Black","year":"2018","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1093\/brain\/awab454","article-title":"Glymphatic system impairment in multiple sclerosis: relation with brain damage and disability.","volume":"45","author":"Carotenuto","year":"2021","journal-title":"Brain"},{"key":"B8","doi-asserted-by":"crossref","first-page":"4908","DOI":"10.1007\/s00415-021-10618-2","article-title":"Neurological update: cognitive rehabilitation in multiple sclerosis.","volume":"268","author":"Chen","year":"2021","journal-title":"J. Neurol."},{"key":"B9","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.103178","article-title":"Progressive brain microstructural damage in patients with multiple sclerosis but not in patients with neuromyelitis optica spectrum disorder: a cross-sectional and follow-up tract-based spatial statistics study.","volume":"55","author":"Chen","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"key":"B10","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1445-5994.2012.02758.x","article-title":"Diabetes as a risk factor for dementia and mild cognitive impairment: a meta-analysis of longitudinal studies.","volume":"42","author":"Cheng","year":"2012","journal-title":"Intern. Med. J."},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2018.01104","article-title":"White matter network disruption and cognitive dysfunction in neuromyelitis optica spectrum disorder.","volume":"9","author":"Cho","year":"2018","journal-title":"Front. Neurol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1136\/jnnp-2022-329628","article-title":"Risk of stroke in multiple sclerosis and neuromyelitis optic spectrum disorder: a nationwide cohort study in South Korea.","volume":"93","author":"Cho","year":"2022","journal-title":"J. Neurol.Neurosurg. Psychiatry"},{"key":"B13","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/ana.21240","article-title":"Multiple sclerosis and Alzheimer\u2019s disease.","volume":"63","author":"Dal Bianco","year":"2008","journal-title":"Ann. Neurol."},{"key":"B14","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000728","article-title":"Is APOE \u03b54 associated with cognitive performance in early MS?","volume":"7","author":"Engel","year":"2020","journal-title":"Neurol. Neuroimmunol. Neuroinflammation"},{"key":"B15","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.amjopharm.2008.06.004","article-title":"Cardiovascular risk factors and dementia.","volume":"6","author":"Fillit","year":"2008","journal-title":"Am. J. Geriatr. Pharmacother."},{"key":"B16","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1093\/brain\/awp070","article-title":"The relation between inflammation and neurodegeneration in multiple sclerosis brains.","volume":"132","author":"Frischer","year":"2009","journal-title":"Brain"},{"key":"B17","doi-asserted-by":"publisher","first-page":"2998","DOI":"10.1093\/brain\/awaa255","article-title":"Vascular disease and multiple sclerosis: a post-mortem study exploring their relationships.","volume":"143","author":"Geraldes","year":"2020","journal-title":"Brain"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/br.2022.1510","article-title":"Neurodegeneration and convergent factors contributing to the deterioration of the cytoskeleton in Alzheimer\u2019s disease, cerebral ischemia and multiple sclerosis.","volume":"16","author":"Guti\u00e9rrez-Vargas","year":"2022","journal-title":"Biomed. Rep."},{"key":"B19","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1161\/HYPERTENSIONAHA.114.03040","article-title":"Hypertension and dementia.","volume":"64","author":"Iadecola","year":"2014","journal-title":"Hypertension"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2019.00105","article-title":"Cognitive profiles of aging in multiple sclerosis.","volume":"11","author":"Jakimovski","year":"2019","journal-title":"Front. Aging Neurosci."},{"key":"B21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41572-020-0214-9","article-title":"Neuromyelitis optica.","volume":"6","author":"Jarius","year":"2020","journal-title":"Nat. Rev. Dis. Primers"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.51506","article-title":"Association of changes in smoking intensity with risk of Dementia in Korea.","volume":"6","author":"Jeong","year":"2023","journal-title":"JAMA Network Open"},{"key":"B23","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.neuropharm.2017.12.030","article-title":"The pathology and pathophysiology of vascular dementia.","volume":"134","author":"Kalaria","year":"2018","journal-title":"Neuropharmacology"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2022.120205","article-title":"Microstructural white matter abnormalities in multiple sclerosis and neuromyelitis optica spectrum disorders: evaluation by advanced diffusion imaging.","volume":"436","author":"Kato","year":"2022","journal-title":"J. Neurol. Sci."},{"key":"B25","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/jnnp-2016-313300","article-title":"Neurodegeneration in multiple sclerosis and neuromyelitis optica.","volume":"88","author":"Kawachi","year":"2017","journal-title":"J. Neurol.Neurosurg. Psychiatry"},{"key":"B26","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1177\/1352458519888609","article-title":"Prevalence and incidence of neuromyelitis optica spectrum disorder and multiple sclerosis in Korea.","volume":"26","author":"Kim","year":"2020","journal-title":"Mult. Scler."},{"key":"B27","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1136\/bmj.322.7300.1447","article-title":"Midlife vascular risk factors and Alzheimer\u2019s disease in later life: longitudinal, population based study.","volume":"322","author":"Kivipelto","year":"2001","journal-title":"BMJ"},{"key":"B28","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.1007\/s00415-020-09969-z","article-title":"Using amyloid PET imaging to diagnose Alzheimer\u2019s disease in patients with multiple sclerosis.","volume":"267","author":"Kolanko","year":"2020","journal-title":"J. Neurol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1212\/WNL.0000000000002067","article-title":"Structural MRI substrates of cognitive impairment in neuromyelitis optica.","volume":"85","author":"Liu","year":"2015","journal-title":"Neurology"},{"key":"B30","doi-asserted-by":"crossref","DOI":"10.3390\/jpm12050743","article-title":"Cognitive performance and health-related quality of life in patients with neuromyelitis optica spectrum disorder.","volume":"12","author":"Lopez-Soley","year":"2022","journal-title":"J. Person. Med."},{"key":"B31","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.msard.2018.10.109","article-title":"Coexistence of multiple sclerosis and Alzheimer\u2019s disease: a review.","volume":"27","author":"Luczynski","year":"2019","journal-title":"Mult. Scler. Relat. Disord."},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2021.103351","article-title":"Diagnosis of Alzheimer\u2019s disease and related dementia among people with multiple sclerosis: large cohort study, USA.","volume":"57","author":"Mahmoudi","year":"2022","journal-title":"Mult. Scle. Relat. Disord."},{"key":"B33","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1177\/1352458514564485","article-title":"A systematic review of the incidence and prevalence of cardiac, cerebrovascular, and peripheral vascular disease in multiple sclerosis.","volume":"21","author":"Marrie","year":"2015","journal-title":"Mult. Scler. J."},{"key":"B34","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1042\/CS20170981","article-title":"Understanding a role for hypoxia in lesion formation and location in the deep and periventricular white matter in small vessel disease and multiple sclerosis.","volume":"131","author":"Martinez Sosa","year":"2017","journal-title":"Clin. Sci."},{"key":"B35","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1212\/WNL.0000000000004741","article-title":"Blood pressure from mid-to late life and risk of incident dementia.","volume":"89","author":"McGrath","year":"2017","journal-title":"Neurology"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2021.102757","article-title":"The prevalence of cognitive impairment in patients with neuromyelitis optica spectrum disorders (NMOSD): a systematic review and meta-analysis.","volume":"49","author":"Moghadasi","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2019.00608","article-title":"Cognitive impairment in neuromyelitis optica spectrum disorders: a review of clinical and neuroradiological features.","volume":"10","author":"Oertel","year":"2019","journal-title":"Front. Neurol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1002\/ana.20703","article-title":"Diagnostic criteria for multiple sclerosis: 2005 revisions to the \u201cMcDonald Criteria\u201d.","volume":"58","author":"Polman","year":"2005","journal-title":"Ann. Neurol."},{"key":"B39","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/S1474-4422(18)30318-1","article-title":"The glymphatic pathway in neurological disorders.","volume":"17","author":"Rasmussen","year":"2018","journal-title":"Lancet Neurol."},{"key":"B40","doi-asserted-by":"crossref","DOI":"10.1007\/s11883-012-0307-3","article-title":"Dyslipidemia and the risk of Alzheimer\u2019s disease.","volume":"15","author":"Reitz","year":"2013","journal-title":"Curr. Atheroscler. Rep."},{"key":"B41","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","article-title":"Alzheimer\u2019s disease.","volume":"397","author":"Scheltens","year":"2021","journal-title":"Lancet"},{"key":"B42","doi-asserted-by":"crossref","DOI":"10.1001\/jamainternmed.2015.7110","article-title":"Korean national health insurance database.","volume":"176","author":"Shin","year":"2016","journal-title":"JAMA Intern. Med."},{"key":"B43","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1136\/jnnp-2021-328519","article-title":"APOE ?4 dose associates with increased brain iron and \u03b2-amyloid via blood\u2013brain barrier dysfunction.","volume":"93","author":"Uchida","year":"2022","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B44","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders.","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"key":"B45","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","article-title":"Revised diagnostic criteria for neuromyelitis optica.","volume":"66","author":"Wingerchuk","year":"2006","journal-title":"Neurology"},{"key":"B46","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1136\/jech-2016-207809","article-title":"Associations between specific autoimmune diseases and subsequent dementia: retrospective record-linkage cohort study, UK.","volume":"71","author":"Wotton","year":"2017","journal-title":"J. Epidemiol. Commun. Health"},{"key":"B47","doi-asserted-by":"crossref","first-page":"6709","DOI":"10.1007\/s12035-015-9593-4","article-title":"Microglia-mediated inflammation and neurodegenerative disease.","volume":"53","author":"Xu","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"B48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-015-0056-1","article-title":"Deletion of aquaporin-4 in APP\/PS1 mice exacerbates brain A\u03b2 accumulation and memory deficits.","volume":"10","author":"Xu","year":"2015","journal-title":"Mol. Neurodegener."}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2023.1214652\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T03:33:42Z","timestamp":1702611222000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2023.1214652\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,15]]},"references-count":48,"alternative-id":["10.3389\/fnins.2023.1214652"],"URL":"https:\/\/doi.org\/10.3389\/fnins.2023.1214652","relation":{},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,15]]},"article-number":"1214652"}}